Integrated proteome and malonylome analyses reveal the potential meaning of TLN1 and ACTB in end-stage renal disease

Table 1 The clinical characteristics of end-stage renal disease (ESRD) patients

	Gender	Age	SCR (umol/l)	BUN (mmol/l)	eGFR (ml/min*1.73 m²)
1	male	33	1569.2	29.68	3.04
2	female	50	937	18.36	3.79
3	male	35	1209.8	20.64	3.37
4	female	63	1189	35.5	2.60
5	female	53	938	19.96	3.71
6	male	56	1384	30.1	3.01
7	female	55	715	28.43	5.08
8	male	41	1305	27.96	3.59
9	male	58	1396.4	21.62	2.94
10	male	39	1210	22.52	3.99
11	male	47	1623.5	26.64	2.65
12	male	40	980	17.64	5.11
13	female	47	644	12.58	6.10
14	male	74	1047	26.3	3.72
15	male	38	926	16.2	5.56
16	female	57	1104	46.56	2.96
17	female	63	818	32.55	4.08
18	female	52	837	18.5	4.29
19	female	61	886	33.1	3.76
20	female	42	1060	25.75	3.46

ISSN: 1477-5956